| Document |
Document Title |
|
WO/2013/165140A1 |
The present invention relates to: a benzyl derivative containing an activated vinyl group; a pharmaceutically acceptable salt thereof; and a pharmaceutical composition containing the compound as an active ingredient. The benzyl derivativ...
|
|
WO/2013/161851A1 |
The present invention pertains to a benzamide derivative represented by formula (I), or a pharmaceutically acceptable salt thereof.
|
|
WO/2013/161437A1 |
An organic light-emitting element, in which a compound represented by general formula (1) is contained in a light-emitting layer. The organic light-emitting element has high luminous efficiency. In the general formula, R1 to R10 independ...
|
|
WO/2013/159026A1 |
This invention relates to novel substituted styryl benzylsulfones that are multikinase inhibitors and pharmaceutically acceptable acid addition salts thereof. The invention also provides compositions comprising a compound of this inventi...
|
|
WO/2013/157229A1 |
[Problem] The present invention provides an alkylphenylsulphide derivative having excellent pest control effect or a salt thereof, a pest control agent containing the same as an active component and a production intermediate thereof. [So...
|
|
WO/2013/153412A1 |
The invention relates to a process for the single step conversion of isomeric mixture of dichlorodipheriyi sulfones to chlorobenzene. The invention further relates a process of using dilute sulfuric acid and re-circulating the dilute sul...
|
|
WO/2013/154080A1 |
The present invention provides: an aryloxyurea compound which can be industrially advantageously synthesized, while having excellent acaricidal activity and/or insecticidal activity and excellent safety, or a salt thereof; and a pest con...
|
|
WO/2013/152170A1 |
Compounds having therapeutic potential as androgen receptor modulators, and methods of making such compounds, are provided. The compounds are structurally related to bicalutamide but bear at least one difluoromethyl or C2 to C5 perfluoro...
|
|
WO/2013/138863A1 |
The present invention relates to kinase inhibitors for the treatment of cancer. Specifically, the present invention relates to the use of aminoactonitrile derivatives (AADs) in the treatment of cancer.
|
|
WO/2013/130436A1 |
The present invention relates to processes for preparing 3-methylsulfonylpropionitrile. The processes provide a good yield and a good purity of the final product and provide a controllable reaction. The present invention also relates to ...
|
|
WO/2013/127841A1 |
The invention is concerned with the compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and X are defined in the detailed description and claims. In addition, the present invention relates to method...
|
|
WO/2013/126438A1 |
The present invention relates to novel thiobenzyl and sulfinylbenzyl derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
|
|
WO/2013/122028A1 |
The purpose of the present invention is to provide an aromatic ring compound exhibiting GPR40 agonist activity. The compound represented by formula (I) (refer to the description for information pertaining to each symbol in the formula) o...
|
|
WO/2013/114987A1 |
The purpose of the present invention is to provide a method of consistently producing high-quality diallylbisphenols with high yields from bisphenols. This method involves steps (1) through (3) below, and enables the consistent productio...
|
|
WO/2013/111864A1 |
Provided is a novel pest control agent. A compound represented by formula (I) or a salt thereof and a pest control agent comprising the same as the active ingredient. In formula (I): R1 and R2 independently represent a hydrogen atom, a h...
|
|
WO/2013/104829A1 |
The invention relates to novel arylamide derivatives having formula (I), and stereoisomers and pharmaceutically acceptable salts thereof, where RA, RB, RC, R', R'', z and X are as defined in the claims. The arylamide derivatives of formu...
|
|
WO/2013/104831A1 |
The invention relates to novel arylamide derivatives having formula (I) and stereoisomers and pharmaceutically acceptable salts thereof, where R2, R8, R9 and R11 are as defined in the claims. The arylamide derivatives of formula (I) have...
|
|
WO/2013/104604A1 |
The invention relates to chiral imidodiphosphates and derivatives thereof having the general formula I, The compounds are suitable as chiral Brønsted acid catalysts, phase-transfer catalysts, chiral anions for organic salts, metal salts...
|
|
WO/2013/104605A2 |
The present invention relates to a process for the asymmetric oxidation of nucleophilic organic compounds, particularly metal-free, with peroxide compounds in the presence of a chiral Bronsted acid catalyst. In one detail, the present in...
|
|
WO/2013/103598A2 |
The present invention provides sulfoxide compounds comprising hydrophobic ester or amide moieties such that the compounds have surfactant properties. Also provided are methods for using the sulfoxide compounds or mixtures of the sulfoxid...
|
|
WO/2013/092350A1 |
The present invention relates to novel N-arylamidine-substituted trifluoroethyl sulfide derivatives of the formula (I) in which X1, X2, X3, X4, R1, R2, R3, n are each defined as specified in the description, to the use thereof as acarici...
|
|
WO/2013/083568A1 |
The invention relates to selective estrogen receptor modulators (SERMs), to methods for the production thereof, to the use thereof to treat and/or prevent diseases, and to the use thereof to produce drugs for the treatment and/or prevent...
|
|
WO/2013/083488A1 |
A sulphur-comprising, fluorinated and sulphonated aromatic alkane monomer which can be used for the manufacture of a polymer membrane intended, for example, for a PEM (Polymer Electrolyte Membrane) fuel cell, said functionalized monomer ...
|
|
WO/2012/031196A9 |
The present invention relates to compounds and compositions for the inhibition of NAMPT, their synthesis, applications and antidotes. An embodiment of the invention is the provision of a compound of Formula IIIA.
|
|
WO/2013/081031A1 |
Provided is an organic electronic material that can produce an organic electronic element that is capable of stable long-term driving and a reduction in driving voltage and that, when caused to be an ink composition, has superior low-tem...
|
|
WO/2013/081052A1 |
Provided are: an organic electronics material that can, at a high yield, produce an organic electronics element that is capable of stable long-term driving and reduced driving voltage and that, when caused to be an ink composition, has s...
|
|
WO/2013/067163A1 |
In one aspect, the invention relates to compounds having the formula: (I) where R1-R6, a, b, and Z are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have neprilysin inhibition activity. I...
|
|
WO/2013/060653A1 |
This invention relates to novel 1-cycloalkyl- or l-heterocyclyl-hydroxyimino-3-phen propanes of the formula wherein R1 to R7 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These...
|
|
WO/2013/030205A1 |
The present application disclosed compounds of Formula I wherein variables R1 and R2 are defined as described herein, which are inhibitors of PARP and provides compounds and compositions containing the compounds of Formula I. The present...
|
|
WO/2013/029338A1 |
Disclosed are novel retinoid-related orphan receptor gamma (RORy) modulators and their use in the treatment of diseases mediated by RORy.
|
|
WO/2013/022919A1 |
A method for treating a p62-mediated disease (e.g., multiple myeloma) in a subject, the method comprising administering to the subject a therapeutically effective amount of at least one p62-ZZ inhibitor compound.
|
|
WO/2013/012665A2 |
Embodiment of the present disclosure can include a compound, a structure bonded to the compound, and the like. In an embodiment, the compound can be a linker between an agent and a structure, where the agent can be a dye or a pigment and...
|
|
WO/2013/010102A2 |
The present invention provides compositions and methods for the administration and targeted delivery, release and/or formation of a drug compound from a halogenated phenol starting compound of the present invention at site(s) within the ...
|
|
WO/2013/009440A1 |
A process wherein an electron donor agent is provided for the decomposition of sulfones and sulfoxides formed after the oxidative desulfurization of a sulfur-containing hydrocarbon stream.
|
|
WO/2012/176856A2 |
To provide a novel pesticide. The present invention provides a compound represented by the formula (I) or its salt, and a pesticide containing it as an active ingredient: (I) wherein each of R1 and R2 is a hydrogen atom, a halogen atom, ...
|
|
WO/2012/171484A1 |
Disclosed is a substituted cyanoaniline compound or a salt thereof, wherein the compound has a structure represented by General Formula I. The compound of General Formula I has broad-spectrum fungicidal activity in the field of agricultu...
|
|
WO/2012/174436A1 |
Disclosed are compounds which are nuclear receptor modulators that can act as antagonists to the androgen receptor, for example, a compound of Formula I: wherein R1 to R5 and X1 to X5 are as described herein, as well as pharmaceutically ...
|
|
WO/2012/167869A1 |
The present invention provides new amino lipids and a convenient method for synthesising these compounds. These (cationic) amino lipids have good properties as transfection agents. The method is an economic versatile two step synthesis a...
|
|
WO/2012/165314A1 |
The present invention provides an amide compound useful as a therapeutic agent for hypertension and the like. The present invention provides a compound represented by general formula (I) [wherein R1: an optionally substituted adamantyl g...
|
|
WO/2012/165648A1 |
The present invention provides a compound having an excellent efficacy for controlling weeds. A cyclohexanone compound of the formula (I): wherein m is an integer of 1, 2 or 3; n is an integer of any one of 1 to 5; X represents CH2, O, S...
|
|
WO/2012/154904A1 |
Disclosed are compounds that inhibit RNase H activity of retroviruses, for example, a compound of formula (I) wherein R1, R2, and R3 are as described herein, as well as pharmaceutically acceptable salts, solvates, stereoisomers, and prod...
|
|
WO/2012/143337A1 |
The present invention relates to novel substituted phenoxyethylamine derivatives, useful as modulators of cortical and basal ganglia dopaminergic and N-methyl-D-aspartate (NMDA) receptor-mediated glutamatergic neurotransmission. In other...
|
|
WO/2012/136428A1 |
Reactive dyes of formula (1), wherein R1 and R2 are each independently of the other hydrogen or unsubstituted or substituted C1-C4alkyl, one of the radicals D1 and D2 is a radical of the formula (2), the other one of the radicals D1 and ...
|
|
WO/2012/136221A1 |
There is provided novel fluoro-substituted compounds capable of modulating the G- protein-coupled receptor GPR40, compositions comprising the compounds, and methods for their use for controlling insulin levels in vivo and for the treatme...
|
|
WO/2012/119941A1 |
The invention relates to compounds of Formula (II) and their use in theraphy as peptidase inhibitors.
|
|
WO/2012/118441A1 |
The present invention provides an efficient and scalable process to prepare the compound of formula 4 by reduction of the corresponding α-acyloxy sulfides.
|
|
WO/2012/116151A2 |
Compounds of formula II are described, wherein D, n, Ra, Rb, and Rc are as herein defined, along with pharmaceutical compositions and methods of using compounds of formula II for treating or reducing the risk of peritoneal carcinomatosis...
|
|
WO/2012/108478A1 |
The present invention is a compound represented by formula (I) (in the formula, each of the reference numerals is as recited in the specification) or a salt thereof.
|
|
WO/2012/098235A1 |
The invention relates to the molecule having formula (I), as well as the enantiomers thereof, and to the use of same in the treatment of ADHD, narcolepsy or idiopathic hypersomnia.
|
|
WO/2012/089644A1 |
A process for preparing 3-alkylsulfinylbenzoyl derivatives of the formula (IIIa) by reaction of 3-alkylsulfinylbenzoic acids of the formula (Ib) with compounds of the formula (II) in the presence of a chlorinating agent and a base is des...
|
